A recent enforcement memo from the U.S. Food and Drug Administration (FDA) signals that the agency will not block a new federal initiative allowing certain hemp-derived cannabidiol (CBD) products to be covered under a Medicare plan — a major change in how these products are treated at the federal level.Under the memo, eligible Medicare patients may be able to receive up to $500 … [Read more...] about FDA Memo Paves Way for CBD to Be Covered by Medicare
CBD
Dr. Oz Unveils Medicare Program Covering CBD and Hemp-Derived THC Products
Dr. Mehmet Oz has announced the launch of a federal pilot program that will allow certain Medicare beneficiaries to access hemp-derived CBD products, with coverage expected to begin as early as 2026. The initiative, developed through the Centers for Medicare & Medicaid Services (CMS), marks a significant shift in how cannabinoid-based products are treated within federal … [Read more...] about Dr. Oz Unveils Medicare Program Covering CBD and Hemp-Derived THC Products
Anti-Marijuana Groups Sue to Block Trump Administration Plan Expanding CBD and THC Coverage Under Medicare
A coalition of anti-marijuana advocacy groups has filed a federal lawsuit aimed at blocking a new Trump administration initiative that would expand access to hemp-derived CBD and THC products through Medicare.The lawsuit, led by Smart Approaches to Marijuana and several allied organizations, challenges the legality of a program being rolled out by the Centers for Medicare & … [Read more...] about Anti-Marijuana Groups Sue to Block Trump Administration Plan Expanding CBD and THC Coverage Under Medicare
From Wild West to Rulebook: White House Eyes CBD Crackdown
The White House is stepping into the cannabis chaos—starting with CBD.Next week, federal officials are holding meetings to review a long-awaited enforcement policy for CBD products, based on guidance from the FDA that still hasn’t been publicly released.Translation:After years of “figure it out yourselves,” the feds might finally decide how they actually want to police this … [Read more...] about From Wild West to Rulebook: White House Eyes CBD Crackdown
The Feds Might Cover CBD… While Accidentally Letting More THC Slide
In one of those “only in cannabis policy” twists, the federal government is moving toward covering CBD under a national health insurance plan—while potentially allowing products that blow past the usual THC limits. Yeah, that contradiction is real. A new Medicare-style pilot program is being built to give patients access to CBD products with a doctor’s … [Read more...] about The Feds Might Cover CBD… While Accidentally Letting More THC Slide
The CBD Party’s Ending—FDA Just Flipped the Lights On
For years, CBD has been living its best life in a regulatory gray zone—sold everywhere, claimed to do everything, and barely bothered by the people in charge. That era might be coming to an end.The FDA just made a quiet but meaningful move, sending a new CBD compliance and enforcement policy to the White House for review. It’s not a full-blown rulebook yet, but it’s the … [Read more...] about The CBD Party’s Ending—FDA Just Flipped the Lights On
Federal Rule Quietly Advances CBD Access Under Medicare Pilot
A federal health policy shift may soon open limited access to hemp-derived CBD for Medicare patients, following reports that regulators finalized a key rule supporting a pilot program.Industry stakeholders say the change was completed weeks ago as part of broader federal cannabis policy adjustments. The initiative is expected to explore whether eligible participants can obtain … [Read more...] about Federal Rule Quietly Advances CBD Access Under Medicare Pilot
CBD Crackdown Looms as Regulators Target Hemp-Derived Products
The regulatory environment surrounding cannabidiol (CBD) and hemp-derived cannabinoid products is entering a period of uncertainty as lawmakers and regulators move toward tighter restrictions nationwide. A combination of federal action and state-level rulemaking could significantly reshape what products remain available on store shelves over the next year. At the federal … [Read more...] about CBD Crackdown Looms as Regulators Target Hemp-Derived Products
CBD vs. Cancer: The Cannabinoid That’s Making Tumors Say “Not Today” (In Labs, Anyway)
In a development that sounds equal parts science and plot twist, a recent scientific review suggests that cannabidiol (CBD)—the non-intoxicating compound derived from cannabis—may hold meaningful potential in the fight against cancer. Far removed from its reputation as a wellness supplement, CBD is increasingly attracting attention for its possible role in disrupting tumor … [Read more...] about CBD vs. Cancer: The Cannabinoid That’s Making Tumors Say “Not Today” (In Labs, Anyway)
From Dispensary Shelf to Federal Spreadsheet: CBD Gets a Medicare Glance
For years, the cannabis industry has operated with one foot in consumer demand and the other firmly outside the federal healthcare system. That long-standing divide may be starting to narrow. A newly outlined federal initiative examining cannabidiol (CBD) within the context of Medicare coverage signals a development the industry has been anticipating for decades: Washington is … [Read more...] about From Dispensary Shelf to Federal Spreadsheet: CBD Gets a Medicare Glance
